About Quotient
Quotient Limited is a diagnostics company. The Company focuses on blood grouping and donor disease screening, which is referred to as transfusion diagnostics. It is engaged in developing, manufacturing and commercializing conventional reagent products used for blood grouping within the global transfusion diagnostics market. It is engaged in developing MosaiQ, which is its technology platform. The Company develops, manufactures and commercializes the products, including antisera products, reagent red blood cells, whole blood controls and ancillary products. Its antisera products contain antibodies used to identify blood group antigens. Its antisera products are monoclonal antibodies manufactured from master cell lines it owns. Its reagent red blood cells products are composed of human red blood cells formulated to enable the identification of blood group antibodies. The Company develops, manufactures and sells conventional reagent products to original equipment manufacturers (OEMs).
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Diagnostic Substances
- Sub-Industry: N/A
- Exchange: NASDAQ
- Symbol: QTNT
- CUSIP:
Key Metrics:
- Previous Close: $7.86
- 50 Day Moving Average: $6.76
- 200 Day Moving Average: $8.34
- 52-Week Range: $14,376,000.00 - $5.67
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -11.39
- P/E Growth: 0.00
- Market Cap: $113.00M
- Outstanding Shares: 14,376,000
- Beta: 1.34
Profitability:- Net Margins: -206.09%
- Return on Equity: -158.73%
- Return on Assets: -44.25%
Debt:- Debt-to-Equity Ratio: 1.00%
- Current Ratio: 1.64%
- Quick Ratio: 1.14%
Additional Links:
Companies Related to Quotient:
Consensus Ratings for Quotient (NASDAQ:QTNT) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.| Ratings Breakdown: | 1 Buy Rating |
| Consensus Rating: | Buy (Score: 3.00) |
| Consensus Price Target: | $28.00 (256.23% upside) |
Analysts' Ratings History for Quotient (NASDAQ:QTNT)
Show:
| Date | Firm | Action | Rating | Price Target | Details |
|---|
| 6/1/2016 | Jefferies Group | Reiterated Rating | Buy | $28.00 |  |
| 1/21/2015 | Robert W. Baird | Downgrade | Outperform -> Neutral | $12.00 | |
(Data available from 9/25/2014 forward)
Earnings History for Quotient (NASDAQ:QTNT)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 10/31/2016 | | | | | | | | |
| 5/23/2016 | Q4 | ($0.59) | ($0.41) | | $5.05 million | View | N/A | |
| 2/8/2016 | Q316 | ($0.76) | ($0.48) | $4.06 million | $4.35 million | View | N/A | |
| 11/2/2015 | Q216 | ($0.80) | ($0.25) | $4.42 million | $4.27 million | View | N/A | |
| 8/3/2015 | Q116 | ($0.67) | ($0.60) | $4.90 million | $4.85 million | View | N/A | |
| 5/18/2015 | Q415 | ($0.52) | ($0.77) | $4.36 million | | View | N/A | |
| 2/4/2015 | | ($0.68) | ($0.51) | | | View | N/A | |
| 11/3/2014 | | ($0.58) | ($0.82) | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Quotient (NASDAQ:QTNT)Current Year EPS Consensus Estimate: $-2.18 EPS
Next Year EPS Consensus Estimate: $-0.69 EPS
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2016 | 2 | ($0.69) | ($0.58) | ($0.64) |
| Q2 2016 | 1 | ($0.54) | ($0.54) | ($0.54) |
| Q3 2016 | 2 | ($0.50) | ($0.46) | ($0.48) |
| Q4 2016 | 1 | ($0.63) | ($0.63) | ($0.63) |
| Q1 2017 | 1 | ($0.71) | ($0.71) | ($0.71) |
| Q2 2017 | 1 | ($0.64) | ($0.64) | ($0.64) |
| Q3 2017 | 1 | ($0.44) | ($0.44) | ($0.44) |
| Q4 2017 | 1 | ($0.36) | ($0.36) | ($0.36) |
| Q1 2018 | 1 | ($0.03) | ($0.03) | ($0.03) |
| Q2 2018 | 1 | ($0.30) | ($0.30) | ($0.30) |
| Q3 2018 | 1 | ($0.28) | ($0.28) | ($0.28) |
| Q4 2018 | 1 | $0.24 | $0.24 | $0.24 |
(Data provided by Zacks Investment Research)
Dividend History for Quotient (NASDAQ:QTNT)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Quotient (NASDAQ:QTNT)Insider Ownership Percentage: 40.50%
Institutional Ownership Percentage: 41.50%
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 8/3/2016 | D J Paul E Cowan | Insider | Buy | 45,455 | $5.50 | $250,002.50 | |
| 8/3/2016 | L John Wilkerson | Director | Buy | 180,000 | $5.50 | $990,000.00 | |
| 6/9/2016 | Jeremy Stackawitz | President | Sell | 15,000 | $10.00 | $150,000.00 | |
| 6/3/2016 | Stephen Unger | CFO | Sell | 14,484 | $9.99 | $144,695.16 | |
| 6/2/2016 | Stephen Unger | CFO | Sell | 8,516 | $10.49 | $89,332.84 | |
| 2/10/2016 | Zubeen Shroff | Director | Buy | 222,222 | $9.00 | $1,999,998.00 | |
| 6/2/2015 | Sarah A Oconnor | Director | Buy | 10,000 | $15.50 | $155,000.00 | |
| 3/13/2015 | Stephen Unger | Insider | Buy | 3,000 | $15.00 | $45,000.00 | |
| 3/3/2015 | Jeremy Stackawitz | President | Sell | 30,000 | $16.80 | $504,000.00 | |
| 3/2/2015 | Jeremy Stackawitz | President | Sell | 4,012 | $16.88 | $67,722.56 | |
| 2/17/2015 | Jeremy Stackawitz | President | Sell | 14,140 | $17.00 | $240,380.00 | |
| 11/28/2014 | Galen Partners V Lp | Major Shareholder | Buy | 157,895 | $9.50 | $1,500,002.50 | |
| 8/7/2014 | Stephen Unger | CFO | Buy | 3,000 | $9.13 | $27,390.00 | |
| 4/30/2014 | Galen Partners V Lp | Major Shareholder | Buy | 312,500 | $8.00 | $2,500,000.00 | |
(Data available from 1/1/2013 forward)
Latest Headlines for Quotient (NASDAQ:QTNT)| Date | Headline |
|---|
 | Quotient Limited Announces Successful Validation of the Initial Manufacturing System for MosaiQ™ Microarrays (NASDAQ:QTNT)
www.publicnow.com - September 9 at 11:44 AM |
 | Quotient Ltd. :QTNT-US: Earnings Analysis: Q1, 2017 By the Numbers : August 15, 2016 (NASDAQ:QTNT)
www.capitalcube.com - August 15 at 7:24 PM |
 | Quotient reports 1Q loss (NASDAQ:QTNT)
sg.finance.yahoo.com - August 9 at 10:13 AM |
| Q1 2017 Quotient Ltd Earnings Release - After Market Close (NASDAQ:QTNT)
biz.yahoo.com - August 8 at 11:45 AM |
| Quotient Limited Announces Closing of Underwritten Offering of Ordinary Shares (NASDAQ:QTNT)
finance.yahoo.com - August 3 at 7:24 PM |
| Quotient Limited to Report First Quarter Fiscal 2017 Financial Results and Host Conference Call (NASDAQ:QTNT)
finance.yahoo.com - August 1 at 8:30 AM |
 | Quotient Limited Announces Pricing of Underwritten Offering of Ordinary Shares (NASDAQ:QTNT)
www.4-traders.com - July 29 at 7:11 PM |
| Quotient Prices 2.8 Million Ordinary Shares (NASDAQ:QTNT)
finance.yahoo.com - July 29 at 9:44 AM |
| Should You Get Rid of Quotient Limited (QTNT) Now? (NASDAQ:QTNT)
finance.yahoo.com - June 23 at 8:43 AM |
 | Quotient Ltd (QTNT.OQ) (NASDAQ:QTNT)
www.reuters.com - June 4 at 9:58 AM |
| Quotient Limited to Participate in Jefferies 2016 Global Healthcare Conference (NASDAQ:QTNT)
finance.yahoo.com - May 31 at 8:30 AM |
| QUOTIENT LTD Files SEC form 10-K, Annual Report (NASDAQ:QTNT)
biz.yahoo.com - May 31 at 6:38 AM |
| Quotient (QTNT) Is in Oversold Territory: What's Next? (NASDAQ:QTNT)
finance.yahoo.com - February 26 at 10:19 AM |
| Quotient (QTNT) Sees Hammer Chart Pattern: Time to Buy? (NASDAQ:QTNT)
finance.yahoo.com - February 17 at 11:06 AM |
| Quotient Ltd. Earnings Analysis: Q3, 2016 By the Numbers (NASDAQ:QTNT)
www.capitalcube.com - February 16 at 2:02 PM |
| QUOTIENT LTD Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits (NASDAQ:QTNT)
biz.yahoo.com - February 9 at 4:57 PM |
| Edited Transcript of QTNT earnings conference call or presentation 8-Feb-16 1:30pm GMT (NASDAQ:QTNT)
finance.yahoo.com - February 8 at 9:29 AM |
| Quotient reports 3Q loss (NASDAQ:QTNT)
sg.finance.yahoo.com - February 8 at 7:59 AM |
| Quotient Limited Reports Third Quarter Fiscal 2016 Financial Results (NASDAQ:QTNT)
finance.yahoo.com - February 8 at 7:45 AM |
 | Trader: Quotient's Public Offering Is 'Priced To Work,' Notes Stock could See Upside (NASDAQ:QTNT)
feeds.benzinga.com - February 5 at 5:38 PM |
| Quotient Gears Up for Secondary Offering (NASDAQ:QTNT)
finance.yahoo.com - February 5 at 8:40 AM |
| 2:57 am Quotient prices 4,444,445 of ordinary shares at $9.00 per share. (NASDAQ:QTNT)
finance.yahoo.com - February 5 at 2:57 AM |
| QUOTIENT LTD Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (NASDAQ:QTNT)
biz.yahoo.com - February 3 at 4:11 PM |
| Quotient Limited Announces Proposed Underwritten Offering of Ordinary Shares (NASDAQ:QTNT)
finance.yahoo.com - February 3 at 4:01 PM |
| Quotient Limited to Report Third Quarter Fiscal 2016 Financial Results and Host Conference Call (NASDAQ:QTNT)
finance.yahoo.com - February 1 at 8:00 AM |
| Quotient Limited Announces Positive Serological Disease Screening Results and Provides MosaiQ™ Development Program Update (NASDAQ:QTNT)
finance.yahoo.com - January 11 at 7:01 AM |
| Quotient Limited to Expand Capability of Its MosaiQ™ Next-Generation Transfusion Diagnostics Platform to Include Nucleic Acid Testing (NASDAQ:QTNT)
finance.yahoo.com - January 11 at 7:00 AM |
| Quotient Limited to Participate in J.P. Morgan 2016 Healthcare Conference (NASDAQ:QTNT)
finance.yahoo.com - December 22 at 2:01 PM |
| Quotient Ltd. Earnings Analysis: Q2, 2016 By the Numbers (NASDAQ:QTNT)
www.capitalcube.com - December 22 at 11:48 AM |
| QUOTIENT LTD Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events (NASDAQ:QTNT)
biz.yahoo.com - December 9 at 4:45 PM |
| Quotient Limited Announces Plans for New Product Development and Manufacturing Facility Near Edinburgh, Scotland (NASDAQ:QTNT)
finance.yahoo.com - December 9 at 4:31 PM |
| QUOTIENT LTD Financials (NASDAQ:QTNT)
finance.yahoo.com - December 8 at 1:17 PM |
 | Quotient Limited (Nasdaq: QTNT) to Ring The Nasdaq Stock Market Closing Bell (NASDAQ:QTNT)
www.noodls.com - November 23 at 10:19 AM |
| Quotient Limited to Ring the NASDAQ Stock Market Closing Bell (NASDAQ:QTNT)
finance.yahoo.com - November 23 at 8:00 AM |
| Quotient Limited to Participate in Canaccord Genuity Medical Technology & Diagnostics Forum (NASDAQ:QTNT)
finance.yahoo.com - November 10 at 4:06 PM |
| QUOTIENT LTD Files SEC form 10-Q, Quarterly Report (NASDAQ:QTNT)
biz.yahoo.com - November 4 at 6:34 PM |
Quotient (NASDAQ:QTNT) Chart for Sunday, September, 25, 2016
